Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections
Introduction: We aimed to demonstrate if fosfomycin tromethamine (FT) treatment could be the treatment of choice in ESBL-producing Enterobacteriaceae strains as an alternative to carbapenem particularly in patients who we would like to treat on an outpatient basis. Methodology; We retrospectivel...
Saved in:
| Main Authors: | Ayhanim Tumturk, Senol Tonyali, Ayse Yasemin Tezer Tekce, Levent Isikay, Hakan Cime |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2019-01-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/10658 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<i>Escherichia coli</i> in Brazilian Poultry Fecal Samples: Co-Carriage of Fosfomycin and ESBL Resistance
by: Felipe Juscele, et al.
Published: (2025-03-01) -
Molecular characterization of beta-lactamase genes produced by community-acquired uropathogenic Escherichia coli in Nouna
by: Dramane Kiemde, et al.
Published: (2020-11-01) -
Tigecycline and intravenous fosfomycin zone breakpoints equivalent to the EUCAST MIC criteria for Enterobacteriaceae
by: Fernando Pasteran, et al.
Published: (2012-02-01) -
Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2020-04-01) -
Risk factors for the acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospitalized children
by: Luciana Robino, et al.
Published: (2013-04-01)